Characteristics of COPPAR Study Subjects at Time of Enrollment
387 Patients(PsA patients: 259, PsO patients: 128) Enrolled as of Feb 2024



Disease Characteristics


Medicines and Supplements Usage

Self-reported Cormorbidities





387 Patients(PsA patients: 259, PsO patients: 128) Enrolled as of Feb 2024